Anti-malarial chemoprophylaxis following evacuation from Afghanistan

J R Army Med Corps. 2012 Mar;158(1):38-40; discussion 40. doi: 10.1136/jramc-158-01-09.

Abstract

UK forces deployed to Afghanistan between March and November are prescribed anti-malarial chemoprophylaxis (AMC). In 2007 an audit showed poor pre-injury AMC compliance and a prescription rate of 50% amongst those casualties evacuated to Role 4. We re-audited the post-deployment AMC prescribing practice for casualties from Afghanistan for the 2008 and half of the 2009 malaria season. Using the Role 4 prescribing information and communication system (PICS), a retrospective AMC search for Proguanil, Chloroquine, Doxycycline, Mefloquine and Malarone was performed on these casualties. Only five out of 305 (1.64%) inpatients were prescribed appropriate post-deployment AMC medication. Awareness of the need to prescribe AMC following evacuation remains poor, and may be improved by recording AMC compliance in field medical records and modifying the PICS software.

MeSH terms

  • Afghan Campaign 2001-
  • Antimalarials / therapeutic use*
  • Atovaquone / therapeutic use
  • Chemoprevention
  • Chloroquine / therapeutic use
  • Clinical Audit
  • Doxycycline / therapeutic use
  • Drug Combinations
  • Drug Prescriptions / statistics & numerical data*
  • Humans
  • Malaria / prevention & control*
  • Mefloquine / therapeutic use
  • Military Personnel*
  • Proguanil / therapeutic use

Substances

  • Antimalarials
  • Drug Combinations
  • atovaquone, proguanil drug combination
  • Chloroquine
  • Doxycycline
  • Proguanil
  • Mefloquine
  • Atovaquone